Capillary leak syndrome cost-effectiveness of therapy

	Capillary leak syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Capillary leak syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Surgery
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Capillary leak syndrome cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Capillary leak syndrome cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Capillary leak syndrome cost-effectiveness of therapy
CDC on Capillary leak syndrome cost-effectiveness of therapy
Capillary leak syndrome cost-effectiveness of therapy in the news
Blogs on Capillary leak syndrome cost-effectiveness of therapy
Directions to Hospitals Treating Capillary leak syndrome
Risk calculators and risk factors for Capillary leak syndrome cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S

Overview

Treatment	Mechanism of Action
Endothelial signal transduction
Bevacizumab	Bevacizumab costs in 2014 averaged around $9324 for a total duration of 8 weeks The average price of the drug was $66.60 per 10 mg given at 5 mg given every 2 weeks ^[1]
Epoprostenol
Theophylline + Terbutaline	Theophylline Terbutaline
Immune modulation
Corticosteroids
Infliximab
IVIG
Plasmapheresis